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We have previously determined that sustained phospho-
lipase D (PLD) activation is associated with differentiation
induction in primary mouse epidermal keratinocytes. We
therefore investigated the effect of two bacterial PLD on
keratinocyte proliferation and differentiation. We found
that Streptomyces sp. PLD was much less potent at inhibit-
ing proliferation than S. chromofuscus PLD, with a half-
maximal inhibitory concentration of 0.05 versus less than
0.001 IU per ml for S. chromofuscus PLD. Similarly, S.
chromofuscus PLD stimulated transglutaminase activity
more effectively and potently than S. sp. PLD. When we
examined the formation of products by the two PLD,
we found that the S. sp. PLD showed higher activity at
all concentrations. Whereas the PLD from S. sp. is
relatively inactive on sphingomyelin, S. chromofuscus PLD
is known to hydrolyze both glycerophospholipids and
sphingomyelin. Based on recent data indicating a role
for ceramide in regulating cell growth and differentiation,
There is accumulating evidence for a role of lipid signalingsystems other than phosphoinositide-specific phospho-lipase C in regulating various cellular processes (reviewedin Exton, 1990; Liscovitch, 1992; Hannun, 1994;Liscovitch and Cantley, 1994; Zhang and Kolesnick,
1995). In particular, both phospholipase D (PLD)-mediated phospholi-
pid hydrolysis and sphingomyelinase-catalyzed sphingomyelin hydro-
lysis are thought to result in the production of lipid second messengers.
PLD activity yields phosphatidic acid (PA), which may itself be a lipid
signal or may be dephosphorylated by phosphatidate phosphohydrolase
to form diacylglycerol (DAG). Sphingomyelinase, on the other hand,
generates ceramide, which, like DAG, activates particular effector
enzymes. In the case of DAG, the effector enzyme is protein kinase
C, a family of phospholipid-dependent protein kinase isoforms
(reviewed in Nishizuka, 1995). It is likely that ceramide also functions
through a protein kinase, the recently discovered ceramide-activated
protein kinase, but it may also regulate the activity of a protein
phosphatase (reviewed in Hannun, 1994; Zhang and Kolesnick, 1995).
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we hypothesized that the ability of S. chromofuscus PLD
to hydrolyze sphingomyelin might underlie its greater
potency. Therefore, we examined the effect of exogenous
sphingomyelinase and synthetic ceramides on DNA syn-
thesis. We found that sphingomyelinase exhibited a potent
concentration-dependent effect on [3H]thymidine
incorporation, much like S. chromofuscus PLD. Synthetic
cell-permeable ceramides (C6- and C2-ceramide) also
concentration dependently inhibited DNA synthesis, with
a half-maximal inhibitory concentration of µ12 µM.
Finally, we obtained evidence suggesting that ceramide
is generated in response to a physiologically relevant
agent, because tumor necrosis factor-a, a known effector
of sphingomyelin turnover in other systems and a
cytokine that is produced and released by keratinocytes,
increased ceramide levels in primary epidermal
keratinocytes. Key words: diacylglycerol/phosphatidic acid/
phospholipase D/tumor necrosis factor-a. J Invest Dermatol
110:318–323, 1998
Both of these pathways have been shown to modulate differentiated
functions in several cell systems. For instance, PLD activity has been
suggested to underlie chemotactic peptide-stimulated superoxide anion
formation and degranulation of neutrophils (Billah et al, 1989), phorbol
ester-induced prostaglandin production by a kidney cell line (Sciorra
and Daniel, 1996), insulin-elicited glucose uptake in a skeletal muscle
cell line (Standaert et al, 1996), angiotensin II-mediated aldosterone
secretion from adrenal glomerulosa cells (Bollag et al, 1990), and
gonadotropin-releasing hormone-stimulated steroidogenesis in ovarian
granulosa cells (Liscovitch and Amsterdam, 1989). The sphingomyelin
pathway has also been implicated in regulating differentiation, as agents
that induce monocytic differentiation of HL-60 leukemic cells [1,25-
dihydroxyvitamin D3, tumor necrosis factor-α (TNF-α), and inter-
feron-γ] trigger sphingomyelin hydrolysis, and synthetic ceramides and
exogenous sphingomyelinase can mimic these effects (Okazaki et al,
1989; Okazaki et al, 1990; Kim et al, 1991). The role of these two
signaling systems (PLD activation and/or sphingomyelin hydrolysis) in
keratinocytes is unclear; however, PLD has been implicated in the
sustained elevation in DAG content and induction of differentiation
in response to ganglioside GQ1b (Yada et al, 1991; Seishima et al,
1995), and synthetic cell-permeant ceramides have been reported to
inhibit proliferation and stimulate differentiation (Wakita et al, 1994)
in a human squamous cell carcinoma cell line.
We have recently shown that bradykinin, which triggers phosphoino-
sitide turnover in keratinocytes (Talwar et al, 1990; Johnson et al,
1992), also activated PLD in primary mouse epidermal keratinocytes.1
Interestingly, however, this activation was transient, such that PLD
activity returned to basal levels by 15 min in the continued presence
of the hormone. In addition, we proposed that the transience of the
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response underlies the minimal effect of bradykinin on keratinocyte
growth, in contrast to the phorbol ester 12-O-tetradecanoyl 13-
phorbol acetate, which both profoundly inhibited proliferation and
elicited sustained PLD activation.1
In this study we examine the effects of two exogenous PLD on
keratinocyte growth and differentiation. One PLD from Streptomyces
chromofuscus is known to hydrolyze both sphingomyelin and glyceropho-
spholipids (Imamura and Horiuti, 1979); the other from Streptomyces
sp. is reported to be relatively inactive towards sphingomyelin (Dr.
Greg Wall, Sigma Technical Service, personal communication, and
Table I). We found that the glycerophospholipid specific S. sp. PLD
was less potent than the S. chromofuscus PLD in inhibiting DNA synthesis
and stimulating transglutaminase activity, a marker of keratinocyte
differentiation. Furthermore, bacterial sphingomyelinase and synthetic
ceramides were able to produce similar effects, suggesting a role
for sphingomyelin turnover and ceramide generation in regulating
keratinocyte growth and differentiation. Finally, we provide evidence
that this signaling pathway may have a physiologic role in keratinocytes
because TNF-α, a cytokine produced by these cells (Wood et al, 1992),
increased ceramide levels.
MATERIALS AND METHODS
Cell culture Primary epidermal keratinocytes were prepared from 2 to 3 d
old neonatal ICR mice (Harlan Sprague Dawley) according to the method of
Marcelo et al (1978). Briefly, after trypsinization of the skin, the epidermis was
mechanically separated from the dermis and epidermal cells were released by
scraping. These cells were then purified by centrifugation through Ficoll and
plated in 6 well dishes (Corning, Corning, NY; or Falcon, Franklin Lakes, NJ)
in a fetal bovine serum-containing RPMI medium. After 4 h, the cells were
washed with phosphate-buffered saline lacking calcium and magnesium (PBS–)
and re-fed with serum-free keratinocyte medium (SFKM), containing 25 µM
calcium, 90 µg bovine pituitary extract per ml, ITS (5 µg insulin per ml 1 5 µg
transferrin per ml 1 5 ng selenious acid per ml), 5–6 ng epidermal growth
factor per ml, 2 mM glutamine, 0.05% bovine serum albumin, 100 U penicillin
per ml, 100 µg streptomycin per ml, and 0.25 µg fungizone per ml, as in Bollag
et al (1993). Cells were re-fed with fresh medium every 1–3 d.
Measurement of DNA synthesis For measurement of [3H]thymidine
incorporation, near-confluent cultures (at densities indicated in the
figure legends) were re-fed with SFKM containing various concentrations of
the indicated agents. After 24 h in the presence of these agents, cells were
labeled with 1 µCi [3H]thymidine per ml for 1 h. Cultures were washed twice
with PBS– and reactions terminated using ice-cold 5% trichloroacetic acid.
Cells were washed with an additional volume of 5% trichloroacetic acid and
with distilled water, and were solubilized in 0.3 M NaOH. An aliquot of this
NaOH extract was counted in a liquid scintillation spectrometer (Packard,
Sterling, VA).
For density determination, following trypsinization, a single-cell suspension
was generated by repeated aspiration of the cells through an 18 gauge
needle and the cells enumerated using an electronic particle counter (Coulter
Electronics, Hialeah, FL).
Measurement of transglutaminase activity Near-confluent keratinocytes
were incubated for 18 h with the indicated amounts of bacterial PLD in SFKM.
The cells were then washed with PBS–, scraped into homogenization buffer
[0.1 M Tris-acetate, pH 7.8, 2 µg aprotinin per ml, 2 µM leupeptin,
1 µM pepstatin A, 0.2 mM ethylenediaminetetraacetic acid (EDTA), 0.2 mM
phenylmethylsulfonyl fluoride, and 0.1% β-mercaptoethanol], placed into micro-
centrifuge tubes and pelleted by centrifugation. The supernatants were removed
and the cell pellets subjected to one freeze-thaw cycle prior to disruption by
sonication in homogenization buffer. Aliquots of the homogenate were incubated
for 14 h at 37°C with 2 µCi per sample [3H]putrescine in a reaction mixture
containing 1% dimethylated Hammerstein casein, 0.1 M Tris-acetate (pH 8.5),
10 mM CaCl2, 0.1 mM EDTA, 5 mM dithiothreitol, and 0.1% Triton X-100
(final concentrations). Reactions were terminated by adding trichloroacetic acid
(to a final concentration of 5%) and the samples filtered through glass fiber
filters. After thorough washing with 5% trichloroacetic acid, the filters were
counted by liquid scintillation spectrometry. Protein content of the samples was
1 Jung EM, Betancourt-Calle S, Mann-Blakeney R, Bollag WB. Sustained
phospholipase D activation is associated with keratinocyte differentiation.
Carcinogenesis, manuscript in revision.
Table I. Streptomyces chromofuscus PLD hydrolyzes
sphingomyelin
Treatmenta [3H]Sphingomyelin (% control)
Control 100
S. chromofuscus PLD 25.9 6 6.6b,d
S. sp. PLD 82.2 6 0.5c
Sphingomyelinase 24.3 6 0.7b,d
a[3H]Choline-labeled lipid extracts were incubated for 60 min with 1 IU per PLD per
ml from S. chromofuscus or S. sp. or with 0.05 U PLD per ml from B. cereus sphingomyelinase.
Radiolabeled sphingomyelin remaining following treatment was then determined as
described in Materials and Methods and expressed as a percentage of the control (untreated)
sample. Data represent the means (6 SEM) of three experiments performed in duplicate
with control values of 23,370 6 54, 23,490 645, and 12,350 6 100 dpm per sample.
bp,0.001 versus control.
cp,0.05 versus control.
dp,0.001 versus S. sp. PLD.
determined using the micro-BCA protein assay (Pierce, Rockford, IL) with
bovine serum albumin as standard.
Measurement of radiolabeled PA and phosphatidylethanol (PEt)
production Radiolabeled PA and PEt production was measured in [3H]oleate-
prelabeled primary epidermal keratinocytes as in Bollag et al (1990). Briefly,
near-confluent cells were labeled in SFKM containing 2.5 µCi [3H]oleic acid
per ml for 20–24 h. The medium was then aspirated and replaced with SFKM
lacking radiolabel. After a 30 min preincubation period, cells were stimulated
with the appropriate agonists and incubated for 30 min in the presence of 0.5%
ethanol. The cells were then solubilized in 0.2% sodium lauryl sulfate containing
5 mM EDTA and extracted for 1–2 h with ice-cold chloroform/methanol to
which acetic acid (1:2:0.04 vol:vol:vol) was added. Additional chloroform and
0.2 M NaCl were added to break phase, and the lower phases were collected
and dried under N2. Samples were resuspended in chloroform/methanol, also
containing 25–50 µg PEt (Biomol, Plymouth Meeting, PA) and PA (Sigma, St.
Louis, MO) per sample, and spotted onto heat-activated silica gel 60 thin-layer
chromatography plates (0.25 mm thickness aluminum-backed with concentrat-
ing zone). Plates were developed in a solvent system consisting of the organic
phase of a mixture of ethyl acetate/iso-octane/acetic acid/water (13:2:3:10)
and were visualized with iodine vapor and with autoradiography using En3Hance
(New England Nuclear/Dupont, Boston, MA). Spots corresponding to PA and
PEt, identified by comigration with authentic standards, were cut out, placed
in liquid scintillation fluid, and quantitated.
Sphingomyelin hydrolysis Primary epidermal keratinocytes were labeled
for µ48 h with 0.1 µCi [3H]choline per ml. After extensive washing with
PBS–, the cells were scraped in ice-cold methanol, transferred to test tubes
containing chloroform and water in a final ratio of 2:1:0.8 vol:vol:vol and
extracted for 1–2 h on ice. Additional volumes of chloroform and 0.2 M NaCl
were added to break phase (for a final ratio of 2:2:1.6 chloroform:methanol:aque-
ous phase), and the lower phases collected. The lower phases were washed
with methanol and 0.2 M NaCl and dried under N2. The [
3H]choline-labeled
lipid extracts were resuspended in sphingomyelinase buffer (100 mM Tris,
pH 7.4, 6 mM MgCl2, 0.1% Triton X100) by incubation at 37°C and vigorous
vortexing. Aliquots were transferred to clean test tubes and S. chromofuscus PLD,
S. sp. PLD, Bacillus cereus sphingomyelinase, or sphingomyelinase buffer (control)
alone was added. The samples were incubated for 60 min at 37°C and reactions
terminated by the addition of methanol. Lipids were extracted as above and
the sphingomyelin present in each sample assayed using the method of Linardic
and Hannun (1994). Briefly, lipid extracts were resuspended in sphingomyelinase
buffer and 1 U S. sp. sphingomyelinase per ml was added. After incubation for
µ90 min, reactions were terminated by addition of chloroform and methanol,
and [3H]choline released into the aqueous phase (a measure of sphingomyelin
present in the original sample) was determined following extraction according
to the method of Folch et al (1957). We have confirmed the specificity of the
assay in our laboratory using [3H]choline-labeled phosphatidylcholine and
sphingomyelin (unpublished data).
Ceramide content Ceramide content was determined using the DAG kinase
assay. Briefly, cells were incubated in SFKM in the presence and absence of
10 nM TNF-α for 1 h. Reactions were terminated by the addition of ice-cold
methanol; after removing the methanol to a clean test tube containing
chloroform, cells were solubilized in 0.2% sodium lauryl sulfate and transferred
to the appropriate test tubes. Lipids were extracted into the chloroform/
methanol phase as described previously and ceramide content was determined
using a bacterial DAG kinase to phosphorylate ceramide in the presence of [γ-
32P]ATP to yield [32P]ceramide phosphate. [32P]ceramide phosphate was then
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separated by thin-layer chromatography and quantitated using a PhosphorImager
(Molecular Dynamics). This method has been previously described for the
measurement of cellular DAG content by Preiss et al (1986), and was modified
by our laboratory (Isales et al, 1989). We have confirmed the linearity of the
assay for determining ceramide content in the range of 10 pmoles to 10 nmoles,
using Type III ceramides (Sigma) as a standard (unpublished data).
Statistical analysis The significance of differences between mean values was
determined using analysis of variance, as performed by the program Instat
(GraphPad Software, San Diego, CA).
Materials Bovine serum albumin (fatty acid-free), trichloroacetic acid,
dimethylated Hammerstein casein, sphingomyelinase (from S. sp. and B. cereus),
phenylmethylsulfonyl fluoride, and PLD from S. sp. and S. chromofuscus were
obtained from Sigma. Note that 1 IU of PLD will hydrolyze 1 µmole of
choline from L-α-phosphatidyl-choline (egg yolk) per minute at 30°C at pH 5.6
(for S. sp. PLD) or pH 8.0 (for S. chromofuscus PLD). [Methyl-3H]thymidine
(specific activity, 40–60 Ci per mmol), [3H]oleic acid, and [3H]putrescine were
purchased from DuPont/NEN (Wilmington, DE). Trypsin inhibitor and
epidermal growth factor were purchased from Gibco (Gaithersburg, MD);
calcium-free minimum essential medium was purchased from Specialty Media
(Lafayette, NJ) or Biologos (Naperville, IL) and RPMI 1640 and PBS– from
Mediatech (Herndon, VA). DAG kinase and the cell-permeant ceramides, N-
acetylsphingosine (C2 ceramide), N-acetylsphinganine (C2 dihydroceramide),
and N-hexanoylsphingosine (C6 ceramide) were obtained from Biomol (Plym-
outh Meeting, PA). Aprotinin, leupeptin, and pepstatin A were purchased from
Boehringer (Indianapolis, IN). Bovine pituitary extract was obtained from
Upstate Biotechnology (P-Neurext; Lake Placid, NY) or Collaborative Research
(Bedford, MA). ITS was purchased from Collaborative Research; all other
tissue culture reagents were obtained from Hazleton Biologics (Lenexa, KS).
Thin-layer chromatography plates were purchased from EM Science
(Gibbstown, NJ). All other materials were of reagent grade.
RESULTS
Streptomyces chromofuscus PLD inhibits growth and stimulates
differentiation of mouse epidermal keratinocytes more potently
than S. sp. PLD As shown in Fig 1, PLD from both S. chromofuscus and
S. sp. inhibited [3H]thymidine incorporation into DNA in primary mouse
epidermal keratinocytes; however, whereas PLD from S. chromofuscus was
effective at very low concentrations (below 0.001 IU per ml), the PLD from
S. sp. exhibited a very different concentration response. S. sp. PLD was much
less potent than that from S. chromofuscus, with a half-maximal inhibitory
concentration (IC50) of 0.05 versus less than 0.001 IU per ml for S. chromofuscus
PLD. At higher concentrations, however, S. sp. PLD exhibited a much greater
inhibitory effect, with a maximal inhibition of µ90% versus about 50%. Boiling
the enzymes completely destroyed their inhibitory effect (data not shown).
Similarly, S. chromofuscus PLD stimulated transglutaminase activity, a
measure of keratinocyte differentiation, more effectively and potently
than S. sp. PLD (Fig 2). Thus, S. chromofuscus PLD elicited an
approximate 3.5-fold increase at 0.05 IU per ml. S. sp. PLD (0.5 IU
per ml), on the other hand, induced only about a maximal 2-fold rise
in transglutaminase activity, which was not statistically significant.
Formation of products by the two PLD is comparable but
S. chromofuscus PLD hydrolyzes sphingomyelin in addition to
glycerophospholipids Because the two bacterial PLD exhibit differ-
ent pH optima (8.0 for S. chromofuscus and 5.6 for S. sp.), we
hypothesized that perhaps S. chromofuscus PLD was more active at
physiologic pH; however, when we examined the radiolabeled PEt, a
novel phospholipid that serves as a marker for PLD activity, and PA
formed by the two PLD (Fig 3), we found that the S. sp. PLD showed
higher activity at all concentrations, including 0.005 IU per ml, a
concentration at which S. chromofuscus PLD was much more effective
at inhibiting DNA synthesis. We therefore hypothesized that the
difference in potency is the result of a more stringent substrate specificity
of S. sp. PLD; S. sp. PLD is reported to be relatively inactive towards
sphingomyelin (Dr. Greg Wall, Sigma Technical Service, personal
communication), whereas S. chromofuscus PLD hydrolyzes both glycero-
phospholipids and sphingomyelin (Imamura and Horiuti, 1979). We
confirmed this specificity on [3H]choline-labeled keratinocyte lipids
in vitro. Table I illustrates that the PLD from S. sp. was relatively
ineffective at hydrolyzing sphingomyelin, whereas the PLD from S.
chromofuscus effectively utilized sphingomyelin as a substrate, hydrolyzing
Figure 1. Exogenous PLD from S. sp. inhibited DNA synthesis less
effectively than the enzyme from S. chromofuscus. Sub- to near-confluent
keratinocytes (an average cell density of 24,000 6 3700 cells per cm2 for S.
chromofuscus and 25,000 6 9000 cells per cm2 for S. sp.) were incubated for
24 h with various amounts of S. sp. (j) or S. chromofuscus (s) PLD, and
[3H]thymidine incorporation into DNA was determined as described in Materials
and Methods. Values are expressed as percentage control (with an average control
of 41,000 6 8000 for S. chromofuscus and 55,000 6 12,000 cpm per well for
S. sp.) and represent the means (6 SEM) of 15–42 samples from at least five
separate experiments for S. chromofuscus and 8–15 samples from three separate
experiments for S. sp.; *p , 0.01 versus control.
about 75% of the total keratinocyte sphingomyelin within 1 h at a pH
of 7.4.
Exogenous sphingomyelinase and cell-permeable ceramides
inhibit proliferation Recent data have indicated a role for sphingo-
myelin turnover, and the resultant production of ceramide, in regulating
growth and differentiation status in several cell systems (reviewed in
Hannun, 1994; Zhang and Kolesnick, 1995). We hypothesized that
the sphingomyelin hydrolysis mediated by S. chromofuscus PLD might
be involved in its potent inhibition of DNA synthesis and stimulation
of differentiation. Therefore, we examined the effects of this sphingo-
myelin hydrolysis and the product generated, ceramide, on keratinocyte
growth and differentiation utilizing exogenous bacterial sphingomyelin-
ase and synthetic ceramides. We found that sphingomyelinase exhibited
a very potent but shallow concentration-dependent effect on [3H]thym-
idine incorporation (Fig 4A), much like S. chromofuscus PLD. An IC50
of µ0.005 U per ml was observed, with a maximal inhibition of about
50% at 0.1 U per ml. Synthetic ceramides (C6- and C2-ceramide) also
showed a concentration-dependent inhibition of DNA synthesis, with
an IC50 of µ12 µM, whereas the inactive isomer dihydroC2-ceramide
(dhC2) inhibited [
3H]thymidine incorporation only at the highest
concentration of 20 µM (Fig 4B). C6-ceramide also stimulated transglut-
aminase activity (unpublished observation). These results concerning
the effects of synthetic ceramides on DNA synthesis and growth are
in agreement with those reported by other investigators in a human
squamous cell carcinoma cell line (Wakita et al, 1994) and HaCaT cells
(Geilen et al, 1996).
TNF-a elevates endogenous ceramide levels and inhibits
proliferation Finally, we have obtained evidence that this growth
inhibition by sphingomyelin turnover may be physiologically relevant.
We have found that TNF-α, a cytokine synthesized by keratinocytes
(Wood et al, 1992) and a known effector of sphingomyelin turnover
in other systems (reviewed in Heller and Kro¨nke, 1994; Zhang and
Kolesnick, 1995), increased ceramide, the product of sphingomyelin
hydrolysis, in primary epidermal keratinocytes. Treatment of near-
confluent keratinocytes for 1 h with 10 nM TNF-α resulted in an
increase of ceramide of 1.41 6 0.16-fold over control (1.00 6 0.04;
VOL. 110, NO. 4 APRIL 1998 CERAMIDE REGULATION OF KERATINOCYTE GROWTH 321
Figure 2. Streptomyces chromofuscus PLD stimulated transglutaminase activity more potently than the enzyme from S. sp.. Sub- to near-confluent
keratinocyte cultures were incubated for 24 h with various amounts of bacterial PLD (from S. chromofuscus or S. sp.) and transglutaminase activity was measured as
[3H]putrescine incorporation into casein, as described in Materials and Methods. (a) A representative experiment performed in duplicate is expressed as cpm of
[3H]putrescine incorporated into casein per mg of protein (6 SEM); *p , 0.05, **p , 0.01 versus control. (b) Average of the mean values from four additional,
separate experiments performed in duplicate are expressed as percentage control 6 SEM (controls were 18.3, 21.3, 52.4, and 585.5 cpm per mg protein for the
four experiments, with the wide variation due to differences in the lots of the casein substrate used); *p , 0.05.
Figure 3. Streptomyces sp. PLD increased product formation more
potently than the enzyme from S. chromofuscus. Near-confluent primary
cultures of mouse epidermal keratinocytes were labeled for 20–24 h with
[3H]oleic acid and then re-fed with SFKM 6 various concentrations of S. sp.
(hatched bars) or S. chromofuscus PLD (striped bars, as indicated) for 30 min in the
presence of 0.5% ethanol. After extracting cellular lipids and separating by thin-
layer chromatography, as described in Materials and Methods, the radioactivity
found in the PLD products, PA and PEt, was quantitated and the results are
presented as -fold over the appropriate control value. Radioactivity in control
samples averaged 25,000 6 6100 cpm per 106 cells for PA and 11,000 6 3000
cpm per 106 cells for PEt, with an average cell density (6 SEM) of
54,000 6 16,000 cells per cm2. Values represent the means (6 SEM) of six to
nine samples from three separate experiments; *p , 0.01.
p , 0.01). These values represent the mean values 6 SEM of 12
samples from six separate experiments.
DISCUSSION
Our finding that S. chromofuscus PLD was more potent than that from
S. sp. in both its growth inhibitory (Fig 1) and its differentiation
stimulatory effects (Fig 2), despite higher activity of the latter enzyme
(Fig 3), suggested that a S. chromofuscus PLD-generated second messen-
ger other than PA, or its metabolite DAG, might be playing a role in
these effects. Imamura and Horiuti (1979) demonstrated that PLD
from S. chromofuscus hydrolyzes sphingomyelin in addition to glycero-
phospholipids, as we have confirmed (Table I), and we hypothesized
that this sphingomyelin degradation might provide an additional
signaling molecule capable of regulating keratinocyte growth. PLD
hydrolysis of sphingomyelin should yield ceramide phosphate, and
presumably this compound, or the ceramide produced by the action
of phosphatidate phosphohydrolase on ceramide phosphate (Waggoner
et al, 1996), can modulate keratinocyte proliferation. Indeed, we have
demonstrated that synthetic cell-permeant ceramides and exogenous
sphingomyelinase both inhibited DNA synthesis (Fig 4). Our results
are consistent with those of Wakita et al (1994), who found that
the cell-permeant ceramides inhibited proliferation and increased
differentiation (e.g., cornified envelope formation, involucrin expres-
sion, and transglutaminase activity) in a human squamous cell carcinoma
cell line. Our data extend this finding to normal mouse epidermal
keratinocytes and provide additional evidence for a role of ceramides
in regulating cellular differentiation status in this epithelial cell system.
Streptomyces sp. PLD also inhibited proliferation, albeit less potently
than that from S. chromofuscus (Fig 1). Nevertheless, the enzyme was
extremely efficacious, and our results suggest that the product of PLD
activity, i.e., PA, can influence keratinocyte growth, either directly or
indirectly, following conversion to DAG. It is possible that the
reported ability of exogenous PA and a bacterial PLD to stimulate
phosphoinositide turnover (Ryder et al, 1993) underlies the growth
inhibitory effect of S. sp. PLD; however, in the study of Ryder et al
(1993), only an approximately half-maximal response is elicited by
13 µM PA, with a threshold concentration of 1.3 µM. Our results
indicate that 0.05 IU per ml S. sp. PLD, a concentration of the enzyme
that should generate only µ50 nmoles of PA per minute in our
system, elicited a significant decrease in [3H]thymidine incorporation.
Moreover, in a previous study (Ryder et al, 1993), the concentration
of (S. chromofuscus) PLD necessary to generate a response comparable
with (although slightly greater than) a concentration of 13 µM PA is
equivalent to 1.67 IU per ml (Ryder et al, 1993), roughly 30 times
the amount of S. sp. PLD necessary to generate a half-maximal response
in terms of DNA synthesis. For these reasons, we believe that the
inhibition of DNA synthesis observed with lower concentrations of S.
sp. PLD is independent of an effect on phosphoinositide turnover.
Instead, we postulate that the PA produced by the action of PLD is
converted to DAG and elicits its effects through protein kinase C,
which is thought to play a role in inhibiting growth and stimulating
differentiation in epidermal keratinocytes (reviewed in Inohara, 1992);
however, a more potent stimulatory effect of S. sp. PLD on phosphoino-
sitide turnover at higher concentrations may contribute to its greater
efficacy in comparison with S. chromofuscus PLD.
Recently, Wakita et al (1996) have shown that the physiologically
relevant cytokine interferon-γ stimulates sphingomyelin hydrolysis in
normal human keratinocytes; however, the method used to measure
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Figure 4. Bacterial sphingomyelinase and synthetic cell-permeant ceramides inhibited DNA synthesis. (a) Near-confluent primary epidermal keratinocyte
cultures (with an average cell density of 37,100 6 5000 cells per cm2) were incubated for 24 h with various concentrations of bacterial sphingomyelinase, and
[3H]thymidine incorporation into DNA was determined as described in Materials and Methods. Values are expressed as percentage control (with an average control
of 38,300 6 12,000 cpm per well) and represent the means (6 SEM) of at least six samples from three separate experiments; *p , 0.001 versus control. (b) Sub-
to near-confluent primary epidermal keratinocyte cultures (with an average cell density of 19,000 6 6100 cells per cm2) were incubated for 24 h with various
concentrations of the active synthetic ceramides N-acetylsphingosine (C2-ceramide, j) or N-hexanoylsphingosine (C6-ceramide, d), or the inactive N-
acetylsphinganine (C2 dihydroceramide, n), and [
3H]thymidine incorporation into DNA was determined as described in Materials and Methods. Values are expressed
as percentage control (with an average control of 31,000 6 1100 cpm per well) and represent the means (6 SEM) of at least nine samples from three separate
experiments; *p , 0.001 versus control.
sphingomyelin degradation utilized a fluorescent sphingomyelin analog
incorporated into the plasma membrane (Wakita et al, 1996). Because
this exogenous sphingomyelin is likely to become incorporated into
the outer leaflet of the lipid bilayer, and should not readily traverse
the membrane, it may not be coupled to sphingomyelinase activity
and function in signaling in the same way as endogenous sphingomyelin.
Indeed, it is not clear why the authors are able to observe interferon-
γ-induced exogenous sphingomyelin hydrolysis, because Linardic and
Hannun (1994) have demonstrated that the signaling pool in HL-60
cells is contained in the inner leaflet of the plasma membrane. Although
it is possible that the 24 h incubation with the fluorescent sphingomyelin
could allow ‘‘flip-flop’’ of the lipid into the inner leaflet, Andrieu et al
(1996) have shown using radiolabeled sphingomyelin that, after a
similar 24 h incubation, as much as 60% of the sphingolipid is still
accessible to exogenous sphingomyelinase, indicating its location in
the outer leaflet of the bilayer. In addition, these authors were
unable to demonstrate TNF-α-induced hydrolysis of the radiolabeled
sphingomyelin under these conditions (Andrieu et al, 1996). Further-
more, and perhaps most importantly, Wakita et al (1996) were unable
to reproduce the cytokine-induced keratinocyte response with synthetic
ceramides or exogenous sphingomyelinase. Nevertheless, the results
support the intriguing idea that interferon-γ may function through
sphingomyelin hydrolysis.
Our data with TNF-α also give support for a role of the sphingomye-
lin signaling system in cytokine-induced regulation of keratinocyte
growth and differentiation. TNF-α is expressed by keratinocytes in
response to perturbations of skin function (Wood et al, 1992), and it
has been proposed that this cytokine is produced by keratinocytes to
regulate immune cells in the skin. The results of Pillai et al (1989),
who found that TNF-α inhibited the growth and stimulated the
differentiation of human keratinocytes, indicates that TNF-α may play
an autocrine regulatory role in mouse keratinocytes as well. Similarly,
we also found that TNF-α concentration dependently inhibited
[3H]thymidine incorporation, with an IC50 of 0.3 nM and a maximal
inhibition of µ30% at 10 nM (data not shown). Furthermore, this
IC50 is nearly identical to the dissociation constant (Kd) calculated by
Pillai et al for the keratinocyte TNF-α receptors (0.28 nM; Pillai et al,
1989). Finally, the ability of TNF-α to elevate cellular ceramide
content suggests that the sphingomyelin hydrolysis pathway may be a
physiologically relevant signaling pathway involved in the action
of this cytokine on keratinocyte growth and differentiation. This
interpretation is supported by the recent findings in HaCaT cells
that indicate that 1,25-dihydroxyvitamin D3 induces sphingomyelin
hydrolysis (Geilen et al, 1996) via release of TNF-α from HaCaT cells
(Geilen et al, 1997). On the other hand, TNF-α has also been reported
to activate a phosphatidylcholine-specific phospholipase C to generate
DAG (reviewed in Heller and Kro¨nke, 1994), which could presumably
activate protein kinase C and potentially influence growth. Further-
more, because ceramides are constituents of the epidermal lipid barrier
(Elias et al, 1979; Madison and Howard, 1996), the TNF-α-elicited
increase in ceramide content may simply reflect a differentiative effect
induced by this cytokine; however, the rapidity of the effect (within
a 1 h exposure) argues against such an interpretation. Moreover, our
results with the cell-permeant ceramides (Fig 4) provide additional
evidence for, but do not prove, a role for ceramides in signaling. We
are currently investigating the contribution of various pathways for
ceramide generation (e.g., from glucosylceramide or sphingomyelin)
to the TNF-α-induced increase in cellular ceramide content.
In conclusion, our results suggest a potential role for TNF-α, the
sphingomyelin hydrolysis signaling pathway, and the lipid messenger
ceramide in the regulation of keratinocyte proliferation and differenti-
ation. In addition, the product of PLD activity, PA, also appears to
modulate keratinocyte growth, either directly or indirectly, upon
conversion to DAG. Moreover, our results suggest that the PLD and
sphingomyelin hydrolysis pathways interact in a synergistic fashion to
inhibit growth and stimulate differentiation of epidermal keratinocytes.
Further investigation into this interaction and into the ability of other
keratinocyte modulators to alter ceramide content and/or PA and
DAG levels (via PLD activation), should provide needed information
concerning the role of these potentially important lipid messengers in
regulating proliferation and differentiation in these cells.
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